AM-Pharma Revenue and Competitors
Estimated Revenue & Valuation
- AM-Pharma's estimated annual revenue is currently $2.9M per year.
- AM-Pharma's estimated revenue per employee is $77,500
- AM-Pharma's total funding is $241.6M.
Employee Data
- AM-Pharma has 38 Employees.
- AM-Pharma grew their employee count by -33% last year.
AM-Pharma's People
Name | Title | Email/Phone |
---|---|---|
1 | General Counsel and VP Business Development | Reveal Email/Phone |
2 | VP Clinical Operations | Reveal Email/Phone |
3 | VP Global Commercial Strategy | Reveal Email/Phone |
4 | VP RA and QM | Reveal Email/Phone |
5 | Chief Operating Officer | Reveal Email/Phone |
6 | Senior Scientific Director | Reveal Email/Phone |
7 | Director Quality Control & Analytical Development | Reveal Email/Phone |
8 | Director, Clinical Trial Site Liaison | Reveal Email/Phone |
9 | Director Pharmacovigilance | Reveal Email/Phone |
10 | Director Pre-Clinical | Reveal Email/Phone |
AM-Pharma Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is AM-Pharma?
AM-Pharma BV is a biopharmaceutical company developing recombinant Alkaline Phosphatase for clinical use.
keywords:N/A$241.6M
Total Funding
38
Number of Employees
$2.9M
Revenue (est)
-33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
AM-Pharma News
Quark Pharmaceuticals Inc., Baxter International Inc., B. Braun Melsungen AG, Asahi Kasei Medical Co. Ltd., AM-Pharma B.V.,...
The major Acute Kidney Injury companies include Atox Bio, AM Pharma Holding, Quark-Pharmaceuticals, LG Chem, Pharming Group, Angion Biomedica,...
UTRECHT, The Netherlands--(BUSINESS WIRE)--AM-Pharma B.V., an emerging leader focused on developing therapeutics for severe medical...
Jenny Life raised $3.5M; SteadyMD closed $6M; Zucara Therapeutics landed $21M Atmosphere Atmosphere is a streaming TV service for businesses. Atmosphere has raised $5 million in fresh Series A funding that brings the total round to $14 million. Backers included Valor Siren Ventures and earlier ...
The Netherlands is one of the largest startup ecosystems in Europe, thanks to the ample innovation and unprecedented digital infrastructure in the country. It is expected that the Netherlands would deliver a couple of billion-dollar worth companies in the coming years. This seems to be possible ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8M | 61 | -10% | N/A |
#2 | $12.5M | 63 | -30% | N/A |
#3 | $14.6M | 64 | 5% | N/A |
#4 | $9M | 69 | 8% | N/A |
#5 | $9.4M | 72 | -6% | N/A |